Your browser doesn't support javascript.
Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients.
Notarbartolo, Samuele; Ranzani, Valeria; Bandera, Alessandra; Gruarin, Paola; Bevilacqua, Valeria; Putignano, Anna Rita; Gobbini, Andrea; Galeota, Eugenia; Manara, Cristina; Bombaci, Mauro; Pesce, Elisa; Zagato, Elena; Favalli, Andrea; Sarnicola, Maria Lucia; Curti, Serena; Crosti, Mariacristina; Martinovic, Martina; Fabbris, Tanya; Marini, Federico; Donnici, Lorena; Lorenzo, Mariangela; Mancino, Marilena; Ungaro, Riccardo; Lombardi, Andrea; Mangioni, Davide; Muscatello, Antonio; Aliberti, Stefano; Blasi, Francesco; De Feo, Tullia; Prati, Daniele; Manganaro, Lara; Granucci, Francesca; Lanzavecchia, Antonio; De Francesco, Raffaele; Gori, Andrea; Grifantini, Renata; Abrignani, Sergio.
  • Notarbartolo S; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Ranzani V; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Bandera A; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Gruarin P; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Bevilacqua V; Centre for Multidisciplinary Research in Health Science (MACH), Università degli Studi di Milano, Milan, Italy.
  • Putignano AR; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Gobbini A; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Galeota E; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Manara C; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Bombaci M; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Pesce E; Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy.
  • Zagato E; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Favalli A; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Sarnicola ML; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Curti S; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Crosti M; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Martinovic M; Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
  • Fabbris T; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Marini F; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Donnici L; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Lorenzo M; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Mancino M; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Ungaro R; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Lombardi A; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, Mainz, Germany.
  • Mangioni D; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Muscatello A; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Aliberti S; INGM, Istituto Nazionale Genetica Molecolare "Romeo ed Enrica Invernizzi", Milan, Italy.
  • Blasi F; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • De Feo T; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Prati D; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Manganaro L; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Granucci F; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Lanzavecchia A; Respiratory Unit and Cystic Fibrosis Adult Center, Respiratory Unit and Cystic Fibrosis Adult Center.
  • De Francesco R; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
  • Gori A; Respiratory Unit and Cystic Fibrosis Adult Center, Respiratory Unit and Cystic Fibrosis Adult Center.
  • Grifantini R; Unità Operativa Complessa (UOC) Coordinamento Trapianti, Fondazione IRCCS Ca' Granda-Ospedale Maggiore Policlinico, Milan, Italy.
  • Abrignani S; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Transfusion Medicine and Hematology, Milan, Italy.
Sci Immunol ; 6(62)2021 08 10.
Article in English | MEDLINE | ID: covidwho-1352519
ABSTRACT
To understand how a protective immune response against SARS-CoV-2 develops over time, we integrated phenotypic, transcriptional and repertoire analyses on PBMCs from mild and severe COVID-19 patients during and after infection, and compared them to healthy donors (HD). A type I IFN-response signature marked all the immune populations from severe patients during the infection. Humoral immunity was dominated by IgG production primarily against the RBD and N proteins, with neutralizing antibody titers increasing post infection and with disease severity. Memory B cells, including an atypical FCRL5+ T-BET+ memory subset, increased during the infection, especially in patients with mild disease. A significant reduction of effector memory, CD8+ T cells frequency characterized patients with severe disease. Despite such impairment, we observed robust clonal expansion of CD8+ T lymphocytes, while CD4+ T cells were less expanded and skewed toward TCM and TH2-like phenotypes. MAIT cells were also expanded, but only in patients with mild disease. Terminally differentiated CD8+ GZMB+ effector cells were clonally expanded both during the infection and post-infection, while CD8+ GZMK+ lymphocytes were more expanded post-infection and represented bona fide memory precursor effector cells. TCR repertoire analysis revealed that only highly proliferating T cell clonotypes, which included SARS-CoV-2-specific cells, were maintained post-infection and shared between the CD8+ GZMB+ and GZMK+ subsets. Overall, this study describes the development of immunity against SARS-CoV-2 and identifies an effector CD8+ T cell population with memory precursor-like features.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunophenotyping / Host-Pathogen Interactions / Transcriptome / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: Sciimmunol.abg5021

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunophenotyping / Host-Pathogen Interactions / Transcriptome / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Year: 2021 Document Type: Article Affiliation country: Sciimmunol.abg5021